Claudine Chollet

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

François‐Xavier Mahon, Françis Belloc, Valérie Lagarde et al. · Blood · 2003 · 538 citations · Full text

Medicine, Molecular Biology, Oncology +11

Mutation in the ATP‐binding site of BCR‐ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571

Christophe Barthe, Marie‐josée Gharbi, Valérie Lagarde et al. · British Journal of Haematology · 2002 · 44 citations · Full text

Medicine, Hematology, Molecular Biology +15

Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.

Marie Colombat, Marie‐Pierre Fort, Claudine Chollet et al. · PubMed · 2006 · 41 citations

Life Sciences, Hematology, Molecular Biology +14

Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr‐Abl–positive cells

Vanessa Desplat, Valérie Lagarde, Françis Belloc et al. · Cytometry Part A · 2004 · 19 citations

Life Sciences, Cell Biology, Molecular Biology +16

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

Gabriel Étienne, Stéphanie Dulucq, Françoise Huguet et al. · Cancer Medicine · 2019 · 19 citations · Full text

Medicine, Hematology, Oncology +15